Holen Sie sich die Stockscreener-App
71.14
3.24%
-2.38
Handel nachbörslich:
71.14
Schlusskurs vom Vortag:
$73.52
Offen:
$73
24-Stunden-Volumen:
1.40M
Relative Volume:
1.20
Marktkapitalisierung:
$11.33B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
32.94
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+8.63%
1M Leistung:
+4.93%
6M Leistung:
+4.77%
1J Leistung:
+9.28%
1-Tages-Spanne:
$70.08
$73.11
1-Wochen-Bereich:
$66.11
$75.71
52-Wochen-Spanne:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
71.14 | 11.33B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
565.94 | 192.17B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
171.02 | 47.90B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.24 | 47.53B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
246.99 | 35.88B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
80.47 | 16.25B | 3.93B | 415.40M | 384.70M | 2.06 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Solventum beats The Street in Q1 and ups revenue guidance - MassDevice
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum Corporation: Cheap, With Caveats (NYSE:SOLV) - Seeking Alpha
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - Zacks Investment Research
Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1 - The Business Journals
Solventum price target lowered to $78 from $80 at Piper Sandler - TipRanks
Solventum Q1 FY25 presentation: raises organic sales outlook despite tariff headwinds - Investing.com
Solventum: Q1 Earnings Snapshot - New Haven Register
Solventum Corp (SOLV) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges - Investing.com Canada
Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54 - TipRanks
Earnings call transcript: Solventum’s Q1 2025 results show mixed performance - Investing.com
Solventum reports Q1 adjusted EPS $1.34, consensus $1.22 - TipRanks
Solventum Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum Reports First Quarter 2025 Financial Results - GuruFocus
Solventum to Participate in the 2025 BofA Securities Health Care Conference - GuruFocus
Solventum Q1 Adjusted Earnings Fall, Sales Rise; 2025 Outlook Reaffirmed - marketscreener.com
Solventum Corp Q1 2025 Earnings: EPS at $0.78, Revenue Hits $2.1 Billion - GuruFocus
Solventum (NYSE:SOLV) Exceeds Q1 Expectations - Yahoo Finance
Solventum Corporation Q1 Profit Decreases, But Beats Estimates - Nasdaq
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses - MSN
Solventum Earnings: What To Look For From SOLV - Yahoo Finance
7 Analysts Assess Solventum: What You Need To Know - Benzinga
Solventum Corporation (SOLV): Among Billionaire Seth Klarman’s Stock Picks with Huge Upside Potential - Insider Monkey
Solventum price target lowered to $80 from $84 at Piper Sandler - TipRanks
Hologic Adds Wayde McMillan to its Board of Directors - Medical Product Outsourcing
Here's What to Expect From Solventum’s Next Earnings Report - Nasdaq
Here's What To Expect From Solventum’s Next Earnings Report - Barchart.com
Solventum Corporation (SOLV): Among the Best New Stocks to Buy According to Billionaires - MSN
Solventum Corporation (SOLV): Among Billionaire Nelson Peltz’s Stock Picks with Highest Upside Potential - Insider Monkey
Should You Be Excited About Solventum Corporation's (NYSE:SOLV) 16% Return On Equity? - simplywall.st
Solventum Stock Price, Quotes and Forecasts - Benzinga
Grin to Launch Digital Care Ecosystem at AAO 2025, Integrate with Clarity by Solventum - Orthodontic Products
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):